中财网 中财网股票行情
复星医药(600196)财务分析指标    年份：
截止日期2025-09-302025-06-302025-03-312024-12-312024-09-30
营业总收入(万元)2939338.541951443.18942032.284106719.593091188.90
营业收入(万元)2939338.541951443.18942032.284106719.593091188.90
营业总成本(万元)2841559.561890436.25913034.223960471.282936281.28
营业成本(万元)1522546.241012346.51492029.602136557.401588959.96
净利润(万元)224246.28165985.7765201.53275365.74183339.47
归属于母公司的净利润(万元)252329.35170196.7876475.78276988.66201064.24
营业利润(万元)390676.54276120.84135877.12424510.39310758.88
利润总额(万元)383734.35271848.16134754.20416928.17307156.59
少数股东损益(万元)53279.8439824.2817680.8574255.3850787.53
基本每股收益(元)0.95(元)0.64(元)0.29(元)1.04(元)0.75(元)
稀释每股收益(元)0.95(元)0.64(元)0.29(元)1.04(元)0.75(元)
非经常性损益(万元)------45553.25--
扣除非经常性损益后净利润(万元)157324.3496078.6541042.14231435.41183624.62
总资产(万元)11812073.8511882793.7111799048.8911746056.7311526476.18
总负债(万元)5730913.865851282.875714058.705752683.845607015.76
归属于母公司股东权益合计(万元)4802850.294739762.374792363.164726110.694730147.31
股东权益合计(万元)6081159.996031510.846084990.195993372.895919460.42
实收资本(股本)(万元)267042.93267042.93267132.65267132.65267132.65
资本公积(万元)1633561.601628729.681666319.121659149.501752464.39
未分配利润(万元)2823379.932741251.862731781.642655305.862582790.67
经营活动产生的现金流量净额(万元)338176.86213400.05105567.99447698.13298663.74
经营活动现金流入小计(万元)3221208.112138899.351043122.494317214.783155192.73
经营活动现金流出小计(万元)2883031.251925499.30937554.503869516.662856529.00
投资活动产生的现金流量净额(万元)-151183.24-85973.70-18509.14-361332.34-243971.25
投资活动现金流入小计(万元)288801.18201266.35127532.42240532.22182376.24
投资活动现金流出小计(万元)439984.43287240.05146041.55601864.56426347.48
筹资活动产生的现金流量净额(万元)-324442.66-146020.03-63362.73-100258.63-50228.94
筹资活动现金流入小计(万元)2686931.481684856.79671176.973336927.492396513.91
筹资活动现金流出小计(万元)3011374.141830876.81734539.703437186.132446742.85
期末现金及现金等价物余额(万元)793613.25921527.55963732.33939144.98947738.84
最后修改日期2025-10-282025-08-272025-04-292025-03-272024-10-30
↑返回页顶↑

转至复星医药（600196）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。